• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔白斑病和口腔鳞状细胞癌唾液代谢组学评价。

Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.

机构信息

Department of Oral Pathology and Microbiology, YMT Dental College and Hospital, Navi Mumbai, India.

Department of Oral and Maxillofacial Pathology and Microbiology, Saveetha Dental College and Hospital, Chennai, India.

出版信息

J Oral Pathol Med. 2019 Apr;48(4):299-306. doi: 10.1111/jop.12835. Epub 2019 Feb 18.

DOI:10.1111/jop.12835
PMID:30714209
Abstract

BACKGROUND

Metabolomics is the study of metabolome which describes the full repertoire of small molecules, and the analysis of salivary metabolomics may help in identifying tumor-specific biomarkers for early diagnosis and prediction of tumor progression. The aim of the study was to evaluate the clinical utility of salivary metabolites in oral leukoplakia and oral squamous cell carcinoma.

METHODS

Salivary metabolomic profile of patients diagnosed with oral leukoplakia (n = 21) and oral squamous cell carcinoma (n = 22) was compared with apparently normal controls (n = 18) using Q-TOF-liquid chromatography-mass spectrometry. MassHunter profile software and Metlin database were used for metabolite identification. ANOVA to identify the regulation of metabolites between the three groups, t test (P < 0.05) to signify the changes between two groups, and chi-square test (P < 0.05) to indicate the presence or absence of metabolites in the study participants of the three groups were performed.

RESULTS

Significant upregulation of 1-methylhistidine, inositol 1,3,4-triphosphate, d-glycerate-2-phosphate, 4-nitroquinoline-1-oxide, 2-oxoarginine, norcocaine nitroxide, sphinganine-1-phosphate, and pseudouridine in oral leukoplakia and OSCC was noted. Downregulated compounds in the diseased groups included l-homocysteic acid, ubiquinone, neuraminic acid, and estradiol valerate.

CONCLUSION

A range of salivary metabolites were significantly altered in oral leukoplakia and oral squamous cell carcinoma. Further, it is necessary to evaluate the clinical utility of the individual metabolites in preventing malignant transformation of oral leukoplakia and to improve prognosis of oral squamous cell carcinoma.

摘要

背景

代谢组学是研究代谢组的,它描述了小分子的全部谱,分析唾液代谢组学可能有助于发现肿瘤特异性生物标志物,用于早期诊断和预测肿瘤进展。本研究旨在评估唾液代谢物在口腔白斑病和口腔鳞状细胞癌中的临床应用价值。

方法

采用 Q-TOF 液相色谱-质谱联用技术比较了 21 例口腔白斑病患者、22 例口腔鳞状细胞癌患者和 18 例貌似正常对照者的唾液代谢组图谱。使用 MassHunter profile 软件和 Metlin 数据库进行代谢物鉴定。采用方差分析(ANOVA)鉴定三组间代谢物的调控,采用 t 检验(P<0.05)比较两组间的变化,采用卡方检验(P<0.05)判断三组研究参与者中代谢物的存在或缺失。

结果

在口腔白斑病和口腔鳞状细胞癌中,1-甲基组氨酸、肌醇 1,3,4-三磷酸、d-甘油酸-2-磷酸、4-硝基喹啉-1-氧化物、2-氧代精氨酸、去甲可卡因氮氧化物、鞘氨醇 1-磷酸和假尿嘧啶显著上调。在病变组中下调的化合物包括 l-高半胱氨酸、泛醌、神经氨酸和戊酸雌二醇。

结论

在口腔白斑病和口腔鳞状细胞癌中,多种唾液代谢物发生了显著改变。进一步评估个体代谢物在预防口腔白斑病恶性转化和改善口腔鳞状细胞癌预后方面的临床应用价值是必要的。

相似文献

1
Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.口腔白斑病和口腔鳞状细胞癌唾液代谢组学评价。
J Oral Pathol Med. 2019 Apr;48(4):299-306. doi: 10.1111/jop.12835. Epub 2019 Feb 18.
2
Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.口腔白斑和口腔鳞状细胞癌中的血清代谢组学
J Cancer Res Ther. 2017 Jul-Sep;13(3):556-561. doi: 10.4103/jcrt.JCRT_1233_16.
3
Salivary metabolite signatures of oral cancer and leukoplakia.口腔癌和白斑的唾液代谢物特征。
Int J Cancer. 2011 Nov 1;129(9):2207-17. doi: 10.1002/ijc.25881. Epub 2011 Apr 13.
4
Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.唾液肿瘤坏死因子-α作为口腔白斑和口腔鳞状细胞癌的生物标志物
Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2087-2093. doi: 10.31557/APJCP.2019.20.7.2087.
5
Salivary biomarkers: Effective diagnostic tool for oral leukoplakia and oral squamous cell carcinoma.唾液生物标志物:口腔白斑病和口腔鳞状细胞癌的有效诊断工具。
Oral Dis. 2024 Sep;30(6):3591-3599. doi: 10.1111/odi.14835. Epub 2023 Dec 14.
6
Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.发育异常性白斑和口腔鳞状细胞癌的唾液蛋白及其早期检测的潜力。
J Proteomics. 2020 Feb 10;212:103574. doi: 10.1016/j.jprot.2019.103574. Epub 2019 Nov 7.
7
Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia.口腔鳞状细胞癌和口腔白斑中唾液内皮素-1水平的评估。
Regul Pept. 2011 Jan 17;166(1-3):55-8. doi: 10.1016/j.regpep.2010.08.006. Epub 2010 Aug 18.
8
Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.唾液 KLK5 和 uPA 是 OLK 和 OLP 恶性转化的潜在生物标志物。
Cancer Biomark. 2021;31(4):317-328. doi: 10.3233/CBM-203105.
9
Evaluation of enzymatic and non-enzymatic antioxidant status and biomarkers of oxidative stress in saliva of patients with oral squamous cell carcinoma and oral leukoplakia: a pilot study.评价唾液中口腔鳞状细胞癌和口腔白斑病患者的酶和非酶抗氧化状态及氧化应激生物标志物:一项初步研究。
Acta Odontol Scand. 2019 Aug;77(6):408-418. doi: 10.1080/00016357.2019.1578409. Epub 2019 Mar 11.
10
Evaluation of salivary and serum lipid peroxidation, and glutathione in oral leukoplakia and oral squamous cell carcinoma.口腔白斑和口腔鳞状细胞癌患者唾液及血清脂质过氧化和谷胱甘肽水平的评估
J Oral Sci. 2014 Jun;56(2):135-42. doi: 10.2334/josnusd.56.135.

引用本文的文献

1
Salivaomic Biomarkers-An Innovative Approach to the Diagnosis, Treatment, and Prognosis of Oral Cancer.唾液生物标志物——口腔癌诊断、治疗和预后的创新方法。
Biology (Basel). 2025 Jul 13;14(7):852. doi: 10.3390/biology14070852.
2
Salivary Metabolomics Discloses Metabolite Signatures of Oral Leukoplakia with and Without Dysplasia.唾液代谢组学揭示了伴有和不伴有发育异常的口腔白斑的代谢物特征。
Int J Mol Sci. 2025 Jul 7;26(13):6519. doi: 10.3390/ijms26136519.
3
Saliva metabolomics: a non-invasive frontier for diagnosing and managing oral diseases.
唾液代谢组学:诊断和管理口腔疾病的无创前沿领域。
J Transl Med. 2025 May 24;23(1):582. doi: 10.1186/s12967-025-06587-z.
4
Malignant Transformed and Non-Transformed Oral Leukoplakias Are Metabolically Different.恶性转化和未转化的口腔白斑在代谢上存在差异。
Int J Mol Sci. 2025 Feb 20;26(5):1802. doi: 10.3390/ijms26051802.
5
The Global Trends and Advances in Oral Microbiome Research on Oral Squamous Cell Carcinoma: A Systematic Review.口腔鳞状细胞癌口腔微生物组研究的全球趋势与进展:一项系统综述
Microorganisms. 2025 Feb 8;13(2):373. doi: 10.3390/microorganisms13020373.
6
Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives.解析人类疾病中的假尿苷碱基修饰:从分子机制到临床视角
Clin Transl Med. 2025 Jan;15(1):e70190. doi: 10.1002/ctm2.70190.
7
Metabolomic Profiling of Oral Potentially Malignant Disorders and Its Clinical Values.口腔潜在恶性疾病的代谢组学分析及其临床价值
Biomedicines. 2024 Dec 19;12(12):2899. doi: 10.3390/biomedicines12122899.
8
Advancements in pseudouridine modifying enzyme and cancer.假尿苷修饰酶与癌症的进展
Front Cell Dev Biol. 2024 Dec 16;12:1465546. doi: 10.3389/fcell.2024.1465546. eCollection 2024.
9
Dysregulation of pseudouridylation in small RNAs contributes to papillary thyroid carcinoma metastasis.小RNA中假尿苷化的失调促进甲状腺乳头状癌转移。
Cancer Cell Int. 2024 Oct 14;24(1):337. doi: 10.1186/s12935-024-03482-3.
10
Implications of RNA pseudouridylation for cancer biology and therapeutics: a narrative review.RNA 假尿嘧啶化对癌症生物学和治疗学的影响:叙述性综述。
J Transl Med. 2024 Oct 7;22(1):906. doi: 10.1186/s12967-024-05687-6.